Literature DB >> 16374258

Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.

Laura T Pizzi1, Christine M Weston, Neil I Goldfarb, Deborah Moretti, Nicole Cobb, Jamie B Howell, Anthony Infantolino, Anthony J Dimarino, Sidney Cohen.   

Abstract

BACKGROUND: Although studies suggest that inflammatory bowel disease (IBD) has a significant impact on an individual's health-related quality of life, the added weight of other health conditions and comorbidities has not been investigated. The purpose of this study was to expand on prior research by taking into account the impact of other chronic health conditions on the health-related quality of life of individuals with IBD, and to develop a model to help clinicians understand the relative impact of various predictors of their patients' physical and mental health-related quality of life.
METHODS: 615 patients from the gastroenterology outpatient practice of a large, urban university hospital received a self-administered survey including questions about their health conditions, the severity of their bowel symptoms, and their health-related quality of life (measured using the SF-36 instrument).
RESULTS: 314 completed surveys were returned, resulting in a response rate of 51.1%. Two regression analyses were conducted to identify the role of patient demographic variables and other chronic conditions on the 2 primary outcomes of interest: the SF-36 Physical Component and Mental Component Summary scores. Statistically significant predictors of physical quality of life included IBD disease severity, arthritis, heart disease, age, anemia, back/shoulder pain, and hypertension; statistically significant predictors of mental health-related quality of life were IBD disease severity, depression/anxiety, age, and headaches.
CONCLUSIONS: IBD disease severity is the most important predictor of both physical and mental health-related quality of life in patients with this condition despite the presence of other chronic conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16374258     DOI: 10.1097/01.mib.0000191670.04605.e7

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  60 in total

Review 1.  Management of Anemia in Patients with Inflammatory Bowel Disease (IBD).

Authors:  Dhruvan Patel; Chinmay Trivedi; Nabeel Khan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

2.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

Review 3.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

4.  Impact of pain on health-related quality of life in patients with inflammatory bowel disease.

Authors:  Anja Schirbel; Anne Reichert; Stephanie Roll; Daniel C Baumgart; Carsten Büning; Bianca Wittig; Bertram Wiedenmann; Axel Dignass; Andreas Sturm
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

5.  Cumulative impact of comorbidity on quality of life in MS.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry
Journal:  Acta Neurol Scand       Date:  2011-05-26       Impact factor: 3.209

6.  Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.

Authors:  Gregory W Munson; Kenneth A Wallston; Robert S Dittus; Theodore Speroff; Christianne L Roumie
Journal:  J Gen Intern Med       Date:  2009-05-15       Impact factor: 5.128

7.  Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis.

Authors:  Zeinab Faghfoori; Rahebeh Shakerhosseini; Lida Navai; Mohammad Hossein Somi; Zeinab Nikniaz; Alireza Abadi
Journal:  Health Promot Perspect       Date:  2014-07-12

Review 8.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 9.  Anemia and inflammatory bowel diseases.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

10.  A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match?

Authors:  Allison R Wilcox; Maria Concepcion C Dragnev; Christopher J Darcey; Corey A Siegel
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.